Cargando…
Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach
In the prevention of epidemic and pandemic viral infection, the use of the antiviral vaccine has been the most successful biotechnological and biomedical approach. In recent times, vaccine development studies have focused on recruiting and targeting immunogens to dendritic cells (DCs) and macrophage...
Autores principales: | Olukitibi, Titus Abiola, Ao, Zhujun, Mahmoudi, Mona, Kobinger, Gary A., Yao, Xiaojian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843631/ https://www.ncbi.nlm.nih.gov/pubmed/31569539 http://dx.doi.org/10.3390/microorganisms7100402 |
Ejemplares similares
-
Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1
por: Ao, Zhujun, et al.
Publicado: (2021) -
Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
por: Olukitibi, Titus Abiola, et al.
Publicado: (2022) -
Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses
por: Ao, Zhujun, et al.
Publicado: (2019) -
Identification and evaluation of the inhibitory effect of
Prunella vulgaris extract on SARS-coronavirus 2 virus
entry
por: Ao, Zhujun, et al.
Publicado: (2021) -
SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production
por: Ao, Zhujun, et al.
Publicado: (2022)